Literature DB >> 1576328

Pharmacokinetics of ketoprofen in rats: effect of age and dose.

J H Satterwhite1, F D Boudinot.   

Abstract

The effects of age and dose on the pharmacokinetics of ketoprofen were evaluated in young adult and senescent male Fischer 344 rats following intravenous administration of 2.5 and 10 mg kg-1. Plasma concentrations were measured by HPLC and free ketoprofen determined by equilibrium dialysis. The glucuronidation of ketoprofen was investigated in a preparation of rat liver microsomes and kinetic analysis of UDP-glucuronyltransferase was carried out by determining the initial rate of metabolic activity as a function of ketoprofen concentration. Mean plasma clearance CLfree and steady-state volume of distribution Vssfree calculated from unbound plasma ketoprofen concentrations were significantly lower in the aged rat, suggesting reduced metabolic activity and decreased ketoprofen binding to tissue components, respectively. Plasma protein binding demonstrated an age-dependent decline due to decreases in both albumin concentration and binding affinity. Thus, plasma clearance CL and steady-state volume of distribution Vss changes were insignificant when total plasma concentrations were examined, due to the greater free fraction of ketoprofen in the plasma of senescent rats. The maximal rate of ketoprofen glucuronidation by hepatic microsomes was reduced whereas the affinity of the metabolic enzymes for the compound was unaffected by age. Dose had a marked effect on the disposition of ketoprofen as well. Saturation of elimination pathways and tissue binding sites contributed to significant declines in CLfree and Vssfree with increasing dose. Likewise, concentration-dependent plasma protein binding occurred, reflecting saturation of albumin binding. Thus, changes in the pharmacokinetic parameters based on total drug concentrations were offset by the increase in the unbound fraction of ketoprofen.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1576328     DOI: 10.1002/bdd.2510130306

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  6 in total

1.  Prediction of sustained fetal toxicity induced by ketoprofen based on PK/PD analysis using human placental perfusion and rat toxicity data.

Authors:  Shingo Tanaka; Takeshi Kanagawa; Kazuo Momma; Satoko Hori; Hiroki Satoh; Takeshi Nagamatsu; Tomoyuki Fujii; Tadashi Kimura; Yasufumi Sawada
Journal:  Br J Clin Pharmacol       Date:  2017-07-27       Impact factor: 4.335

2.  A therapeutic dose of ketoprofen causes acute gastrointestinal bleeding, erosions, and ulcers in rats.

Authors:  Lisa J Shientag; Suzanne M Wheeler; David S Garlick; Louise S Maranda
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-11       Impact factor: 1.232

3.  Predictability of the clinical potency of NSAIDs from the preclinical pharmacodynamics in rats.

Authors:  A Mukherjee; V G Hale; O Borga; R Stein
Journal:  Inflamm Res       Date:  1996-11       Impact factor: 4.575

4.  Possible role for brain prostanoid pathways in the development of angiotensin II-salt hypertension in rats.

Authors:  Ninitha Asirvatham-Jeyaraj; Gregory D Fink
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-05-25       Impact factor: 3.619

5.  Clinical Management of Pain in Rodents.

Authors:  Patricia L Foley; Lon V Kendall; Patricia V Turner
Journal:  Comp Med       Date:  2019-12-10       Impact factor: 0.982

6.  Some pharmacokinetic parameters of R-(-)- and S-(+)-ketoprofen: the influence of age and differing physiological status in dairy cattle.

Authors:  L Igarza; A Soraci; N Auza; H Zeballos
Journal:  Vet Res Commun       Date:  2004-01       Impact factor: 2.459

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.